ClinicalTrials.govpublic full text
Intravenous Immunoglobulin (IVIG) for Resistant Neuropathic Pain
neuropathic pain, resistant, neuroinflammation, neuroinflammatory markers, neuropathic pain that has not responded to standard therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 979534
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.